New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Boyd joins the company from Longboard Pharmaceuticals, where he most recently served as Head of Business Development. Prior to this, he was Vice President of Investor Relations at Oxford Biomedica and ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with Acumen Pharmaceuticals (NASDAQ: ABOS) CEO Daniel O ’ Connell and Jessica ...

Starboard Value on Wednesday nominated three director candidates, including its chief executive and founder, Jeff Smith, to ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with Acumen Pharmaceuticals (NASDAQ: ABOS) CEO Daniel O ' Connell and Jessica Clark, ...

"I am excited to welcome Christopher Cooper as Co-CEO of Shuttle Pharma," commented Dr. Anatoly Dritschilo, Chairman of the Board and CEO of Shuttle Pharma. "Christopher brings a wealth of ...

Supernus Pharmaceuticals CEO will participate in a fireside chat at the TD Cowen Health Care Conference on March 3, 2025. Supernus Pharmaceuticals, Inc., a biopharmaceutical company specializing ...

Marc Forth Steps Down as President and CEO to Pursue Another Opportunity; will remain on the Board of Directors –– Jost Fischer, Chairman of ...

The Law Society of Ontario’s CEO, Diana Miles, “is no longer employed” by the legal regulator following the release of a retired judge’s review into her compensation, sparked by ...

Ryan Khouri, CEO of CTT Pharma Contact Information: CTT Pharma - 813-606-0060 SOURCE: CTT Pharmaceutical Holdings, Inc. View the original press release on ACCESS Newswire ...